Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery | MicrobiomeTrials← Back to trialsNCT06164743
Phase 2: VVN461 Ophthalmic Solution for Post -Operative Ocular Inflammation After Cataract Surgery
CompletedPHASE2INTERVENTIONAL
Trial Details
Start: 2024-01-11Est. Completion: 2024-05-15
Enrollment target: 91 participants Locations- United Medical Research Institute, Inglewood, California, United States
- North Bay Eye Associates, Petaluma, California, United States
- Martel Eye Associates, Rancho Cordova, California, United States
- ICON Eye Care, Grand Junction, Colorado, United States
- Levenson Eye Associates, Jacksonville, Florida, United States
- Comprehensive Eye Care, Ltd, Washington, Missouri, United States
- Center For Sight - Las Vegas, Las Vegas, Nevada, United States
- Cincinnati Eye Institute, Cincinnati, Ohio, United States
- Keystone Research, Austin, Texas, United States
- Houston Eye Associates, Houston, Texas, United States
Other microbiome trials you might be interested in
Sickle Cell Disease
'Sickle-shaped' anemia was first clinically described in the US in 1910, and the mutated heritable sickle hemoglobin mol…
Cleveland, United StatesEst. completion May 31, 2030
Acute-On-Chronic Liver FailureSepsis
This study aims to evaluate the efficacy and safety of the double plasma cytokine adsorption system with sequential low-…
Guangzhou, ChinaEst. completion Oct 31, 2027
Sarcopenia
Intrinsic Capacity
To evaluate the effects of a 12-week multi-component nutritional formula on World Health Organization (WHO) Integrated C…
Kaohsiung City, TaiwanEst. completion Dec 15, 2026